Diagnostic Approach to Pulmonary Hypertension in Premature Neonates

Vasantha H S Kumar1

  • 1Division of Neonatology, Department of Pediatrics, The Women & Children's Hospital of Buffalo, University at Buffalo, 219 Bryant Street, Buffalo, NY 14222-2006, USA. vkumar3@buffalo.edu.

Insights

Bronchopulmonary dysplasia (BPD) with pulmonary hypertension (PH) affects premature infants. Early recognition and management, including pulmonary vasodilators and multidisciplinary care, are crucial for improving outcomes in these high-risk infants.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • Cardiology

Background:

  • Bronchopulmonary dysplasia (BPD) is a chronic lung disease in premature infants.
  • Pulmonary hypertension (PH) is a significant complication of BPD, increasing morbidity and mortality.
  • Infants with risk factors like growth restriction are particularly susceptible to early-onset PH.

Purpose of the Study:

  • To highlight the importance of early recognition and management of PH in infants with BPD.
  • To discuss current diagnostic tools and emerging screening methods for PH in neonates.
  • To review management strategies and factors influencing PH progression in BPD.

Main Methods:

  • Review of current literature on BPD and PH in infants.
  • Discussion of diagnostic modalities including echocardiography, CT, and MRI.
  • Analysis of risk factors, disease progression, and treatment approaches.

Main Results:

  • Alveolar simplification and PH are key features of BPD in survivors.
  • Echocardiography remains the primary non-invasive diagnostic tool for infant PH.
  • Management involves aggressive lung disease care, nutritional support, and pulmonary vasodilators.

Conclusions:

  • Early diagnosis and comprehensive management are vital for infants with BPD and PH.
  • Multidisciplinary care and combination therapies improve outcomes.
  • Further research is needed on the role of advanced imaging and epigenetic factors.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
703
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
533
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
942